Michel Dahan

Insider Reports History

Entity
Individual
Location
C/O Akebia Therapeutics, Inc., 245 First Street, Suite 1100, Cambridge, MA
Signature
/s/ Carolyn Rucci, attorney-in-fact for Michel Dahan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michel Dahan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. SVP, Chief Operating Officer Common Stock 672K $847K $1.26 May 13, 2024 Direct
Akebia Therapeutics, Inc. SVP, Chief Operating Officer Stock Option (Right to buy) 224K Jan 31, 2024 Direct

Insider Reports Filed by Michel Dahan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKBA Akebia Therapeutics, Inc. May 13, 2024 1 -$43.9K 4 May 14, 2024 SVP, Chief Operating Officer
AKBA Akebia Therapeutics, Inc. Feb 29, 2024 1 -$13.7K 4 Mar 1, 2024 SVP, Chief Operating Officer
AKBA Akebia Therapeutics, Inc. Feb 27, 2024 1 -$16.3K 4 Feb 29, 2024 SVP, Chief Operating Officer
AKBA Akebia Therapeutics, Inc. Jan 31, 2024 2 $0 4 Feb 2, 2024 SVP, Chief Operating Officer
AKBA Akebia Therapeutics, Inc. May 24, 2023 3 -$117K 4 May 25, 2023 SVP, Chief Operating Officer
AKBA Akebia Therapeutics, Inc. May 12, 2023 1 $0 4 May 16, 2023 SVP, Chief Operating Officer
AKBA Akebia Therapeutics, Inc. Mar 1, 2023 3 -$17.9K 4 Mar 3, 2023 SVP, Chief Operating Officer
AKBA Akebia Therapeutics, Inc. Feb 27, 2023 1 -$8.21K 4 Mar 1, 2023 SVP, Chief Operating Officer
AKBA Akebia Therapeutics, Inc. Feb 28, 2022 6 -$46.6K 4 Mar 2, 2022 SVP, Chief Operating Officer